TIS tissue therapies limited
Add to My Watchlist 0.00% ! 0.0¢

Ann: Investor Update , page-3

  1. Rock555
    533 Posts.
    lightbulb Created with Sketch. 49
    clock Created with Sketch.
    02/12/11
    09:11
    Post #: 9379642
    The agreement with Quintiles is a true commercial partnership including shared risk and
    reward. Quintiles will provide the sales and marketing staff in relevant markets, as specified by Tissue Therapies in our detailed rollout plan.

    Well they say the have a DETAILED roll out plan, be nice if they let us in on it.
    good luck all
    TIS Price at posting: 42.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Thick zone of high-grade gold mineralisation intersected at Fairview South
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist
right-arrow Created with Sketch.
NEWS La Negra delivers growth with exceptional silver equivalent drill results
right-arrow Created with Sketch.
NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Anson Progresses POSCO Due Diligence with Bulk Green River Brine Shipment to Korea
right-arrow Created with Sketch.
NEWS Mandalay Resources Discovers High-Grade Skarn and Provides Update on Near Mine Exploration at Björkdal
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.